Senator finds GSK profited by pulling asthma inhaler critical for kids
- Posted on March 16, 2026
- By CNN
- 1 Views
Senator finds GSK profited by pulling asthma inhaler critical for kids
In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent off the market. A senator launched an investigation to find out what happened, sharing her findings exclusively with CNN.
